The first lawsuit filed by a state attorney general, California’s Xavier Becerra, over pelvic mesh products went to trial yesterday in San Diego. The lawsuit alleges that Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon concealed the potential risks of pelvic mesh from the public and physicians. It’s the first of several lawsuits brought by state AGs […]
Johnson & Johnson unit loses 9th pelvic mesh case in Philly
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon last week reportedly lost the ninth of eleven product liability lawsuits brought before a Pennsylvania state court when the jury awarded $500,000 in damages to the plaintiff. In handing down the July 28 verdict for Linda Dunfee and her husband Thomas Dunfee, the jury in the Philadelphia County Court […]
Investor lodges class action suit against Boston Scientific over U.S. mesh withdrawal
A plaintiff purporting to represent Boston Scientific shareholders sued the company yesterday, alleging that it misled investors about the prospects for its pelvic mesh products ahead of an FDA order to halt all U.S. sales of the devices. Last week the FDA ordered an immediate halt to sales and distribution of Boston’s Uphold Lite and Xenform products; […]
Plaintiff wins $120m in latest pelvic mesh trial against Johnson & Johnson unit
A state court jury in Philadelphia reportedly slapped Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon with a $120 million verdict yesterday in a product liability lawsuit brought over one of its pelvic mesh products. The jury in the Pennsylvania Court of Common pleas awarded Susan McFarland $20 million in compensatory damages and $100 million in punitive damages after […]
FDA’s pelvic mesh ban spooks investors
The FDA’s ban on U.S. sales of pelvic mesh products for pelvic organ prolapse may have spooked investors, but should only have a minimal effect on the books at Boston Scientific (NYSE:BSX) and Coloplast (CPH:COLO-B) – the only companies still selling mesh for prolapse in the U.S. – according to analysts and the company. Yesterday the […]
Pennsylvania appeals court upholds $14m plaintiff win in Ethicon mesh case
A state appeals court in Pennsylvania yesterday upheld the plaintiff’s $13.7 million win in a product liability lawsuit brought over one of Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon‘s pelvic mesh products. Plaintiff Sharon Carlino was awarded $13.5 million in damages in February 2016, after a Keystone State jury found that the Ethicon transvaginal polypropylene tape […]
Missouri appeals court revives pelvic mesh suit against BD’s Bard
A Missouri state appeals court last week revived a pelvic mesh product liability lawsuit against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard, ruling that a lower court was wrong to exclude prior verdicts that went against the company. Barad and co-defendant Boston Scientific (NYSE:BSX) escaped the suit in February 2016 after a Kansas City jury voted 10-2 […]
Here are the top 5 medtech stories of mid-2018
A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read […]
Boston Scientific wins third Mass. pelvic mesh trial
Boston Scientific (NYSE:BSX) last week won the third Massachusetts trial of a product liability lawsuit brought over two of its pelvic mesh products. Ana Martinez and her husband Jose sued Marlborough, Mass.-based Boston Scientific in August 2012 in the Bay State’s Middlesex County Superior Court. After a 16-day trial, the jury found June 15 that Boston was […]
60 Minutes to speak to Boston Scientific in coverage of pelvic mesh MDL
CBS’s 60 Minutes will speak to Boston Scientific (NYSE:BSX) this week as the news program covers the massive multi-district litigation over gynecological pelvic mesh implants. The program referred to the multi-district litigation over the implants as the largest such litigation since asbestos, according to a press release. In early 2016, the FDA reclassified surgical meshes to […]
UPDATE: New Jersey jury hits BD subsidiary Bard with $68m pelvic mesh verdict
Updated to include a $35 million punitive damages verdict released today. Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard was reportedly hit yesterday with a $33 million verdict in a product liability lawsuit brought over its Avaulta and Align pelvic mesh products. A New Jersey jury in the Bergen County Superior Court awarded $23 million in compensatory […]
- 1
- 2
- 3
- …
- 9
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube